Does craniosacral therapy work, and for what? It's a fair question, and it deserves more than either a dismissal or a sales pitch. The honest picture is that the research base is still developing, the trials we have face real design problems, and millions of people report genuine benefit. All three are true at once.
This article walks through what the clinical research currently shows, why good CST trials are harder to design than they sound, and which conditions have drawn the most research attention.
What systematic reviews have found
The most recent reviews have not found clear statistical evidence that CST works across the conditions it's commonly used for. A 2024 systematic review in Healthcare (PubMed PMID 38540643) looked at 15 randomised controlled trials and concluded that the evidence did not show statistically significant or clinically meaningful changes in pain or disability for headache disorders, neck pain, low back pain, pelvic girdle pain, or fibromyalgia. A separate 2024 meta-analysis in Frontiers in Medicine examined 24 RCTs with 1,613 participants and also found no significant effects in the primary analysis, with only limited signals for neonatal structure and chronic somatic pain among secondary outcomes.
These findings matter and shouldn't be brushed aside. Anyone practising or recommending CST should know about them.
Why CST trials are hard to design
That said, the limits of the existing trials are worth understanding. The standard tool for testing a treatment is the double-blind randomised controlled trial — neither patient nor clinician knows who got the real treatment. That works well for drugs. It's much harder to apply to a hands-on therapy like CST.
Designing a credible sham CST — something that feels like real CST but contains none of the active elements — is genuinely difficult. In most CST trials, the sham is a therapist making light contact without intentional technique. It's not clear how different that is from what an inexperienced or half-present real therapist does. When the control resembles a relaxed version of the real thing, the study will underestimate any real effect.
There are also questions about dose. Most CST trials have used short courses — four to eight sessions — which practitioners often say is too few for longer-standing or complex conditions. The mix of training backgrounds among trial therapists is another problem. A study that lumps together weekend-course practitioners and 700-hour biodynamic graduates isn't measuring the same thing twice.
The fact that 14 of the 24 studies in the Frontiers meta-analysis were rated 'High Risk' of bias tells you something important: most of the trials we have aren't yet good enough to be definitive either way. That isn't pro-CST spin. It's a methodological reality, and it cuts both ways.
Where positive evidence does exist
Despite the mixed picture in systematic reviews, some areas have produced more encouraging results. Chronic neck pain has shown positive findings in several individual trials. Tension-type headache has been a focus of positive studies, and some practitioners report particularly good results with migraine, though the meta-analytic picture is less clear. Stress-related conditions and general nervous system dysregulation are areas where practitioners consistently report benefit. Trial evidence here is limited, but the biological plausibility of gentle touch affecting the autonomic nervous system is more straightforward than some of CST's other theoretical claims.
For infant work — unsettled babies, birth trauma, colic — CST is widely used and parents often report significant improvement. The 2024 reviews were not encouraging about the formal trial evidence here, but trial quality for infant studies has been particularly variable, and many practitioners have deep experience in this area. For premature infant care, some hospital-based studies have shown positive effects on specific neonatal outcomes, which the Frontiers meta-analysis recorded as a signal, though with wide confidence intervals.
The gap between trials and clinic
There's a familiar problem in complementary therapy research: the gap between what RCTs show and what practitioners and clients experience. CST is a clear example. The therapy has been practised in some form for over a century. Hundreds of thousands of people have received it. The amount of positive qualitative evidence — testimonials, practitioners' notes, healthcare professionals who use CST in broader treatment plans — is substantial, even if it doesn't meet the standards of randomised evidence.
None of that proves the mechanism. The theoretical basis of CST — the model of craniosacral rhythm and cranial bone mobility — is contested by mainstream anatomy, and that's a real problem for the field. But the gap between contested mechanism and reported benefit isn't unusual in medicine. Acupuncture's mechanisms aren't fully understood. Many physiotherapy techniques have limited RCT support. The question isn't whether we can perfectly explain the effect. It's whether the effect is real and worth investigating with better trials.
Many practitioners and researchers take the view that what CST reliably produces — a deep settling of the nervous system, a quality of restful contact most people rarely experience — may have real clinical value even if Sutherland's original theory of cranial bone movement doesn't survive scrutiny. The biodynamic tradition in particular has largely moved away from precise mechanistic claims and toward a more phenomenological framing.
If you're considering CST for yourself or someone you care for, the honest answer is that the formal evidence base is mixed and the research is ongoing. The experience of millions of people suggests something is happening, and happening safely. For conditions where other approaches haven't helped, or where you're after deep nervous system support rather than a quick fix, it's a reasonable thing to try with a well-trained practitioner — with realistic expectations and without giving up other forms of care.